Press Release Core Scientific, Inc. Releases Webcast and Presentation with Updates on Chapter 11 Emergence 22 January 2024
Press Release Eight-Year Data for Opdivo (nivolumab) Plus Yervoy (ipilimumab) Continue to Demonstrate Longest Survival Benefit vs. Sunitinib Reported in Patients with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma 22 January 2024
Press Release Cushman & Wakefield to Release Fourth Quarter and Full Year 2023 Earnings on February 20 22 January 2024
Press Release Principal® CEO Dan Houston to Speak at 2024 Bank of America Financial Services Conference 22 January 2024
Press Release Opdivo® (nivolumab) in Combination with CABOMETYX® (cabozantinib) Demonstrates Long-Term Survival Benefits After Four Years of Follow-Up in the CheckMate -9ER Trial in First-Line Advanced Renal Cell Carcinoma 22 January 2024
Press Release Independent Bank Group, Inc. Reports Fourth Quarter Financial Results and Declares Quarterly Dividend 22 January 2024
Press Release Multiple New Analyses Reinforce the Role of BAVENCIO® (avelumab) First-Line Maintenance as a Standard of Care in Patients with Locally Advanced or Metastatic Urothelial Carcinoma 22 January 2024
Press Release Excelerate Energy Announces Fourth Quarter and Full Year 2023 Earnings Conference Call Date 22 January 2024
Press Release Baron & Budd Environmental Practice Named to Law360’s 2023 Practice Group of the Year 22 January 2024
